ANAGENICS LIMITED - Announcements

0.00%

0.7¢

Market Cap $3.474M

Consumer Defensive Household & Personal Products

Anagenics Limited is an Australia-based health and beauty-tech company that operates... Anagenics Limited is an Australia-based health and beauty-tech company that operates health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. The Company operates through its holding entity, Anagenics Limited and its main operating subsidiary company BLC Cosmetics Pty Limited (BLC) being a distributor of prestige beauty cosmetics and beauty equipment. BLC is an importer and distributor of prestige international and local skin care and wellbeing brands, namely Thalgo, Comfort Zone, Priori and other premium brands. BLC services over 1,000 spas, clinics, salons, retail stores and online in Australia, New Zealand and the Pacific Islands. The Company's brands consist of evolis and Uspa. Evolis is an anti-ageing hair care collection focused on harnessing the scientific research to give customers' thicker and healthier hair.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AN1	Change of Director's Interest Notice-Cross		13/09/18	254.07KB	Share
AN1	Change of Director's Interest Notice-Eck		13/09/18	253.4KB	Share
AN1	Change of Director's Interest Notice-Gordon		13/09/18	254.14KB	Share
AN1	Change of Director's Interest Notice-Halasz		13/09/18	351.44KB	Share
AN1	Cleansing Notice		12/09/18	196.78KB	Share
AN1	Appendix 3B		12/09/18	862KB	Share
AN1	Lead Antibody Effective in Rare Chronic Kidney Disease	PRICE SENSITIVE	12/09/18	31.77KB	Share
AN1	Results of Meeting		07/09/18	407.57KB	Share
AN1	EGM Presentation by CEO		07/09/18	3.14MB	Share
AN1	Company Secretary Appointment/Resignation		06/09/18	194.96KB	Share
AN1	Cellmid Share Purchase Plan Completion	PRICE SENSITIVE	03/09/18	129.32KB	Share
AN1	Evolis USA Distribution Update	PRICE SENSITIVE	30/08/18	110.21KB	Share
AN1	Preliminary Final Report	PRICE SENSITIVE	24/08/18	217.28KB	Share
AN1	Cellmid Notice of Meeting		06/08/18	140.12KB	Share
AN1	Cleansing Notice and Appendix 3B	PRICE SENSITIVE	06/08/18	387.46KB	Share
AN1	Cellmid Share Purchase Plan	PRICE SENSITIVE	31/07/18	149.47KB	Share
AN1	Cellmid Share Placement Raises $9M	PRICE SENSITIVE	31/07/18	106.44KB	Share
AN1	Appendix 4C and Notes to Appendix 4C	PRICE SENSITIVE	31/07/18	300.39KB	Share
AN1	Trading Halt	PRICE SENSITIVE	27/07/18	141.88KB	Share
AN1	CELLMID UPDATES ON DISTRIBUTION OF EVOLIS	PRICE SENSITIVE	11/07/18	178.82KB	Share
AN1	CELLMID INVESTOR PRESENTATION		02/07/18	2.51MB	Share
AN1	MIDKINE SYMPOSIUM MUNICH		30/05/18	289.39KB	Share
AN1	CHANGE OF ADDRESS		29/05/18	147.97KB	Share
AN1	CELLMID TO COMMENCE SELLING OF EVOLIS INTO CHINESE MARKET	PRICE SENSITIVE	02/05/18	182.71KB	Share
AN1	CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLIS	PRICE SENSITIVE	24/04/18	90.04KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/18	114.53KB	Share
AN1	Cellmid Investor Presentation		10/04/18	2.49MB	Share
AN1	CELLMID CONVENING 5TH MIDKINE SYMPOSIUM IN MUNICH		09/04/18	92.7KB	Share
AN1	CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINA	PRICE SENSITIVE	04/04/18	320.39KB	Share
AN1	Change of Director's Interest Notice-Halasz		29/03/18	285.49KB	Share
AN1	Initial Director's Interest Notice		26/03/18	9.49KB	Share
AN1	CELLMID APPOINTS DENNIS ECK NON-EXECUTIVE DIRECTOR		26/03/18	24.71KB	Share
AN1	Change of Director's Interest Notice-Halasz		14/03/18	229.11KB	Share
AN1	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	22/02/18	209.54KB	Share
AN1	Change of Director's Interest Notice-Halasz		31/01/18	229.35KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	25/01/18	232.07KB	Share
AN1	RECORD 2M SALES FOR CELLMID FGF5 INHIBITORS	PRICE SENSITIVE	10/01/18	63.89KB	Share
AN1	CELLMID QUARTERLY OPERATIONAL UPDATE	PRICE SENSITIVE	09/01/18	93.09KB	Share
AN1	Change of Director's Interest Notice-Halasz		22/12/17	228.93KB	Share
AN1	Cleansing Statement & Appendix 3B		19/12/17	193.4KB	Share
AN1	CELLMID PLACEMENT TO STRATEGIC INVESTOR	PRICE SENSITIVE	15/12/17	68.34KB	Share
AN1	CELLMID SECURES NEW US RETAIL PARTNER FOR EVOLIS	PRICE SENSITIVE	07/12/17	97.36KB	Share
AN1	CELLMID CAPITAL STRUCTURE POST CONSOLIDATION		05/12/17	60.87KB	Share
AN1	YPB: Agreement with Cellmid to access Chinese health market	PRICE SENSITIVE	28/11/17	199.4KB	Share
AN1	CELLMID SIGNS AGREEMENT WITH YPB FOR CHINA MARKET		28/11/17	352.35KB	Share
AN1	CHANGE OF AUDITOR		24/11/17	58.42KB	Share
AN1	Update - Consolidation/Split - CDY		23/11/17	33KB	Share
AN1	Results of Annual General Meeting		23/11/17	249.52KB	Share
AN1	AGM Presentation to Shareholders		23/11/17	1.69MB	Share
AN1	Appendix 3B-Unlisted options		16/11/17	426.9KB	Share
AN1	ASIC Form 484		15/11/17	8.87KB	Share
AN1	Change of Director's Interest Notice-Halasz		15/11/17	73.35KB	Share
AN1	Appendix 3E and 3F		15/11/17	93.54KB	Share
AN1	Change of Director's Interest Notice-Halasz		07/11/17	229.12KB	Share
AN1	Change of Director's Interest Notice-Cross		01/11/17	257.77KB	Share
AN1	Change of Director's Interest Notice-Walton		01/11/17	259.16KB	Share
AN1	Initial Director's Interest Notice		31/10/17	42.06KB	Share
AN1	Change of Director's Interest Notice-King		31/10/17	225.41KB	Share
AN1	Change of Director's Interest Notice-Halasz		31/10/17	229.5KB	Share
AN1	CELLMID PRESENTS AT WORLD CONGRESS FOR HAIR RESEARCH		31/10/17	96.19KB	Share
AN1	CELLMID OPENS FIRST CONCEPT STORE IN TOKYO	PRICE SENSITIVE	26/10/17	82.25KB	Share
AN1	Announcement of buy-back - Appendix 3C		25/10/17	244.31KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/17	105.48KB	Share
AN1	PROPOSED CONSOLIDATION OF SECURITIES	PRICE SENSITIVE	24/10/17	86.65KB	Share
AN1	Consolidation/Split - CDY	PRICE SENSITIVE	23/10/17	25.22KB	Share
AN1	Cellmid Annual Report to Shareholders		23/10/17	2.41MB	Share
AN1	Notice of Annual General Meeting/Proxy Form		23/10/17	255.2KB	Share
AN1	CELLMID APPOINTS DR MARTIN CROSS AS NON-EXECUTIVE DIRECTOR		16/10/17	197.93KB	Share
AN1	Date of Annual General Meeting		12/10/17	60.52KB	Share
AN1	CELLMID RECEIVES $947K R&D TAX CREDIT	PRICE SENSITIVE	03/10/17	20.35KB	Share
AN1	PROACTIVE INVESTORS EVENTS		03/10/17	17.2KB	Share
AN1	INVESTORS PRESENTATION		27/09/17	3.43MB	Share
AN1	CHANGE OF SHARE REGISTRY DETAILS		25/09/17	19.65KB	Share
AN1	Change of Director's Interest Notices		04/09/17	120.99KB	Share
AN1	Appendix 4G and Corporate Governance		30/08/17	960.71KB	Share
AN1	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	30/08/17	602.28KB	Share
AN1	CELLMID COMPLETES US CONSUMER STUDY	PRICE SENSITIVE	21/08/17	120.25KB	Share
AN1	CELLMID SECURES PREMIUM US RETAIL CHANNEL FOR EVOLIS	PRICE SENSITIVE	03/08/17	80.66KB	Share
AN1	Chinese Import Permits Received	PRICE SENSITIVE	01/08/17	86.07KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	28/07/17	325.45KB	Share
AN1	Nature Paper MK in Melanoma	PRICE SENSITIVE	03/07/17	135.5KB	Share
AN1	Change of Director's Interest Notice-Halasz		05/06/17	285.28KB	Share
AN1	Appendix 3B		15/05/17	423.45KB	Share
AN1	Change of Director's Interest Notice-Halasz		15/05/17	284.68KB	Share
AN1	Change of Director's Interest Notice-Halasz		12/05/17	73.65KB	Share
AN1	Company Secretary Appointment/Resignation		27/04/17	58.51KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	19/04/17	76.34KB	Share
AN1	Change of Director's Interest Notice - Halasz		16/03/17	106.71KB	Share
AN1	Response to ASX query on Appendix 3Y		13/03/17	297.31KB	Share
AN1	CELLMIDS FGF5 INHIBITOR CLINICAL STUDY PUBLISHED	PRICE SENSITIVE	02/03/17	109.33KB	Share
AN1	Cellmid to Refinance R&D Loan Facility	PRICE SENSITIVE	01/03/17	335.81KB	Share
AN1	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	28/02/17	464.85KB	Share
AN1	MIDKINE ALOPECIA PATENT EUROPEAN ALLOWANCE	PRICE SENSITIVE	07/02/17	79.03KB	Share
AN1	CELLMID'S USA MIDKINE PATENT FOR ALOPECIA ALLOWED	PRICE SENSITIVE	31/01/17	95.59KB	Share
AN1	Appendix 4C	PRICE SENSITIVE	24/01/17	2.09MB	Share
AN1	CELLMID RECEIVES AUSTRALIAN GOVT GRANT FOR MIDKINE PROGRAMME	PRICE SENSITIVE	18/01/17	102.46KB	Share
AN1	Change of Director's Interest Notice - Halasz		18/01/17	285KB	Share
AN1	Cellmid Updates on CxBladder License	PRICE SENSITIVE	12/12/16	84.33KB	Share
AN1	Cellmid receives 831K R&D tax credit	PRICE SENSITIVE	29/11/16	75.44KB	Share
AN1	Results of Annual General Meeting		21/11/16	58.19KB	Share

AN1 Change of Director's Interest Notice-Cross
13/09/18		254.07KB	Share
AN1 Change of Director's Interest Notice-Eck
13/09/18		253.4KB	Share
AN1 Change of Director's Interest Notice-Gordon
13/09/18		254.14KB	Share
AN1 Change of Director's Interest Notice-Halasz
13/09/18		351.44KB	Share
AN1 Cleansing Notice
12/09/18		196.78KB	Share
AN1 Appendix 3B
12/09/18		862KB	Share
AN1 Lead Antibody Effective in Rare Chronic Kidney Disease
12/09/18	PRICE SENSITIVE	31.77KB	Share
AN1 Results of Meeting
07/09/18		407.57KB	Share
AN1 EGM Presentation by CEO
07/09/18		3.14MB	Share
AN1 Company Secretary Appointment/Resignation
06/09/18		194.96KB	Share
AN1 Cellmid Share Purchase Plan Completion
03/09/18	PRICE SENSITIVE	129.32KB	Share
AN1 Evolis USA Distribution Update
30/08/18	PRICE SENSITIVE	110.21KB	Share
AN1 Preliminary Final Report
24/08/18	PRICE SENSITIVE	217.28KB	Share
AN1 Cellmid Notice of Meeting
06/08/18		140.12KB	Share
AN1 Cleansing Notice and Appendix 3B
06/08/18	PRICE SENSITIVE	387.46KB	Share
AN1 Cellmid Share Purchase Plan
31/07/18	PRICE SENSITIVE	149.47KB	Share
AN1 Cellmid Share Placement Raises $9M
31/07/18	PRICE SENSITIVE	106.44KB	Share
AN1 Appendix 4C and Notes to Appendix 4C
31/07/18	PRICE SENSITIVE	300.39KB	Share
AN1 Trading Halt
27/07/18	PRICE SENSITIVE	141.88KB	Share
AN1 CELLMID UPDATES ON DISTRIBUTION OF EVOLIS
11/07/18	PRICE SENSITIVE	178.82KB	Share
AN1 CELLMID INVESTOR PRESENTATION
02/07/18		2.51MB	Share
AN1 MIDKINE SYMPOSIUM MUNICH
30/05/18		289.39KB	Share
AN1 CHANGE OF ADDRESS
29/05/18		147.97KB	Share
AN1 CELLMID TO COMMENCE SELLING OF EVOLIS INTO CHINESE MARKET
02/05/18	PRICE SENSITIVE	182.71KB	Share
AN1 CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLIS
24/04/18	PRICE SENSITIVE	90.04KB	Share
AN1 Appendix 4C - quarterly
23/04/18	PRICE SENSITIVE	114.53KB	Share
AN1 Cellmid Investor Presentation
10/04/18		2.49MB	Share
AN1 CELLMID CONVENING 5TH MIDKINE SYMPOSIUM IN MUNICH
09/04/18		92.7KB	Share
AN1 CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINA
04/04/18	PRICE SENSITIVE	320.39KB	Share
AN1 Change of Director's Interest Notice-Halasz
29/03/18		285.49KB	Share
AN1 Initial Director's Interest Notice
26/03/18		9.49KB	Share
AN1 CELLMID APPOINTS DENNIS ECK NON-EXECUTIVE DIRECTOR
26/03/18		24.71KB	Share
AN1 Change of Director's Interest Notice-Halasz
14/03/18		229.11KB	Share
AN1 Appendix 4D and Half Year Accounts
22/02/18	PRICE SENSITIVE	209.54KB	Share
AN1 Change of Director's Interest Notice-Halasz
31/01/18		229.35KB	Share
AN1 Appendix 4C - quarterly
25/01/18	PRICE SENSITIVE	232.07KB	Share
AN1 RECORD 2M SALES FOR CELLMID FGF5 INHIBITORS
10/01/18	PRICE SENSITIVE	63.89KB	Share
AN1 CELLMID QUARTERLY OPERATIONAL UPDATE
09/01/18	PRICE SENSITIVE	93.09KB	Share
AN1 Change of Director's Interest Notice-Halasz
22/12/17		228.93KB	Share
AN1 Cleansing Statement & Appendix 3B
19/12/17		193.4KB	Share
AN1 CELLMID PLACEMENT TO STRATEGIC INVESTOR
15/12/17	PRICE SENSITIVE	68.34KB	Share
AN1 CELLMID SECURES NEW US RETAIL PARTNER FOR EVOLIS
07/12/17	PRICE SENSITIVE	97.36KB	Share
AN1 CELLMID CAPITAL STRUCTURE POST CONSOLIDATION
05/12/17		60.87KB	Share
AN1 YPB: Agreement with Cellmid to access Chinese health market
28/11/17	PRICE SENSITIVE	199.4KB	Share
AN1 CELLMID SIGNS AGREEMENT WITH YPB FOR CHINA MARKET
28/11/17		352.35KB	Share
AN1 CHANGE OF AUDITOR
24/11/17		58.42KB	Share
AN1 Update - Consolidation/Split - CDY
23/11/17		33KB	Share
AN1 Results of Annual General Meeting
23/11/17		249.52KB	Share
AN1 AGM Presentation to Shareholders
23/11/17		1.69MB	Share
AN1 Appendix 3B-Unlisted options
16/11/17		426.9KB	Share
AN1 ASIC Form 484
15/11/17		8.87KB	Share
AN1 Change of Director's Interest Notice-Halasz
15/11/17		73.35KB	Share
AN1 Appendix 3E and 3F
15/11/17		93.54KB	Share
AN1 Change of Director's Interest Notice-Halasz
07/11/17		229.12KB	Share
AN1 Change of Director's Interest Notice-Cross
01/11/17		257.77KB	Share
AN1 Change of Director's Interest Notice-Walton
01/11/17		259.16KB	Share
AN1 Initial Director's Interest Notice
31/10/17		42.06KB	Share
AN1 Change of Director's Interest Notice-King
31/10/17		225.41KB	Share
AN1 Change of Director's Interest Notice-Halasz
31/10/17		229.5KB	Share
AN1 CELLMID PRESENTS AT WORLD CONGRESS FOR HAIR RESEARCH
31/10/17		96.19KB	Share
AN1 CELLMID OPENS FIRST CONCEPT STORE IN TOKYO
26/10/17	PRICE SENSITIVE	82.25KB	Share
AN1 Announcement of buy-back - Appendix 3C
25/10/17		244.31KB	Share
AN1 Appendix 4C - quarterly
25/10/17	PRICE SENSITIVE	105.48KB	Share
AN1 PROPOSED CONSOLIDATION OF SECURITIES
24/10/17	PRICE SENSITIVE	86.65KB	Share
AN1 Consolidation/Split - CDY
23/10/17	PRICE SENSITIVE	25.22KB	Share
AN1 Cellmid Annual Report to Shareholders
23/10/17		2.41MB	Share
AN1 Notice of Annual General Meeting/Proxy Form
23/10/17		255.2KB	Share
AN1 CELLMID APPOINTS DR MARTIN CROSS AS NON-EXECUTIVE DIRECTOR
16/10/17		197.93KB	Share
AN1 Date of Annual General Meeting
12/10/17		60.52KB	Share
AN1 CELLMID RECEIVES $947K R&D TAX CREDIT
03/10/17	PRICE SENSITIVE	20.35KB	Share
AN1 PROACTIVE INVESTORS EVENTS
03/10/17		17.2KB	Share
AN1 INVESTORS PRESENTATION
27/09/17		3.43MB	Share
AN1 CHANGE OF SHARE REGISTRY DETAILS
25/09/17		19.65KB	Share
AN1 Change of Director's Interest Notices
04/09/17		120.99KB	Share
AN1 Appendix 4G and Corporate Governance
30/08/17		960.71KB	Share
AN1 Appendix 4E and Preliminary Final Report
30/08/17	PRICE SENSITIVE	602.28KB	Share
AN1 CELLMID COMPLETES US CONSUMER STUDY
21/08/17	PRICE SENSITIVE	120.25KB	Share
AN1 CELLMID SECURES PREMIUM US RETAIL CHANNEL FOR EVOLIS
03/08/17	PRICE SENSITIVE	80.66KB	Share
AN1 Chinese Import Permits Received
01/08/17	PRICE SENSITIVE	86.07KB	Share
AN1 Appendix 4C - quarterly
28/07/17	PRICE SENSITIVE	325.45KB	Share
AN1 Nature Paper MK in Melanoma
03/07/17	PRICE SENSITIVE	135.5KB	Share
AN1 Change of Director's Interest Notice-Halasz
05/06/17		285.28KB	Share
AN1 Appendix 3B
15/05/17		423.45KB	Share
AN1 Change of Director's Interest Notice-Halasz
15/05/17		284.68KB	Share
AN1 Change of Director's Interest Notice-Halasz
12/05/17		73.65KB	Share
AN1 Company Secretary Appointment/Resignation
27/04/17		58.51KB	Share
AN1 Appendix 4C - quarterly
19/04/17	PRICE SENSITIVE	76.34KB	Share
AN1 Change of Director's Interest Notice - Halasz
16/03/17		106.71KB	Share
AN1 Response to ASX query on Appendix 3Y
13/03/17		297.31KB	Share
AN1 CELLMIDS FGF5 INHIBITOR CLINICAL STUDY PUBLISHED
02/03/17	PRICE SENSITIVE	109.33KB	Share
AN1 Cellmid to Refinance R&D Loan Facility
01/03/17	PRICE SENSITIVE	335.81KB	Share
AN1 Appendix 4D and Half Year Accounts
28/02/17	PRICE SENSITIVE	464.85KB	Share
AN1 MIDKINE ALOPECIA PATENT EUROPEAN ALLOWANCE
07/02/17	PRICE SENSITIVE	79.03KB	Share
AN1 CELLMID'S USA MIDKINE PATENT FOR ALOPECIA ALLOWED
31/01/17	PRICE SENSITIVE	95.59KB	Share
AN1 Appendix 4C
24/01/17	PRICE SENSITIVE	2.09MB	Share
AN1 CELLMID RECEIVES AUSTRALIAN GOVT GRANT FOR MIDKINE PROGRAMME
18/01/17	PRICE SENSITIVE	102.46KB	Share
AN1 Change of Director's Interest Notice - Halasz
18/01/17		285KB	Share
AN1 Cellmid Updates on CxBladder License
12/12/16	PRICE SENSITIVE	84.33KB	Share
AN1 Cellmid receives 831K R&D tax credit
29/11/16	PRICE SENSITIVE	75.44KB	Share
AN1 Results of Annual General Meeting
21/11/16		58.19KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.7¢		Change 0.000(0.00%)		Mkt cap ! $3.474M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	1544100	0.6¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	364754	3

View Market Depth

No.	Vol.	Price($)
2	1544100	0.006
1	750000	0.005
6	7665000	0.004
3	5450000	0.003
1	800000	0.002

Price($)	Vol.	No.
0.007	364754	3
0.008	653713	2
0.009	620000	2
0.010	500000	1
0.015	200000	1

Last trade - 16.21pm 08/08/2025 (20 minute delay)

AN1 (ASX) Chart

Day chart unavailable

ANAGENICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available